Wolverine Asset Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-12,989
| Closed | -$16K | – | 1426 |
|
|
2017
Q4 | $16K | Buy |
12,989
+2,315
| +22% | +$2.85K | ﹤0.01% | 875 |
|
|
2017
Q3 | $22K | Buy |
10,674
+7,874
| +281% | +$16.2K | ﹤0.01% | 780 |
|
|
2017
Q2 | $8K | Hold |
2,800
| – | – | ﹤0.01% | 768 |
|
|
2017
Q1 | $9K | Buy |
+2,800
| New | +$9K | ﹤0.01% | 711 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 1063 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 1070 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 1107 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 1411 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 1492 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 1510 |
|
|
2015
Q2 | – | Sell |
-210
| Closed | -$16K | – | 1501 |
|
|
2015
Q1 | $16K | Sell |
210
-700
| -77% | -$53.3K | ﹤0.01% | 922 |
|
|
2014
Q4 | $55K | Sell |
910
-7,030
| -89% | -$425K | ﹤0.01% | 907 |
|
|
2014
Q3 | $338K | Buy |
+7,940
| New | +$338K | 0.01% | 658 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 1615 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 1844 |
|
|
2013
Q4 | – | Sell |
-2,650
| Closed | -$162K | – | 1840 |
|
|
2013
Q3 | $162K | Hold |
2,650
| – | – | ﹤0.01% | 881 |
|
|
2013
Q2 | $154K | Buy |
+2,650
| New | +$154K | ﹤0.01% | 817 |
|